Tomasz Wichur

512 total citations
14 papers, 427 citations indexed

About

Tomasz Wichur is a scholar working on Pharmacology, Computational Theory and Mathematics and Physiology. According to data from OpenAlex, Tomasz Wichur has authored 14 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 12 papers in Computational Theory and Mathematics and 8 papers in Physiology. Recurrent topics in Tomasz Wichur's work include Cholinesterase and Neurodegenerative Diseases (13 papers), Computational Drug Discovery Methods (12 papers) and Alzheimer's disease research and treatments (8 papers). Tomasz Wichur is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (13 papers), Computational Drug Discovery Methods (12 papers) and Alzheimer's disease research and treatments (8 papers). Tomasz Wichur collaborates with scholars based in Poland, Slovenia and Spain. Tomasz Wichur's co-authors include Barbara Malawska, Justyna Godyń, Anna Więckowska, Stanislav Gobec, Dawid Panek, Damijan Knez, Anna Pasieka, Jakub Jończyk, Marek Bajda and Jan Korábečný and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and European Journal of Medicinal Chemistry.

In The Last Decade

Tomasz Wichur

14 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomasz Wichur Poland 10 339 249 164 130 126 14 427
Luisa Ceccarini Italy 8 263 0.8× 220 0.9× 121 0.7× 167 1.3× 111 0.9× 8 438
Qing Song China 16 320 0.9× 231 0.9× 204 1.2× 99 0.8× 132 1.0× 22 495
Martín Estrada Spain 14 276 0.8× 155 0.6× 198 1.2× 162 1.2× 95 0.8× 21 500
Beyza Ayazgök Türkiye 13 233 0.7× 177 0.7× 173 1.1× 76 0.6× 78 0.6× 19 383
Paula Zaręba Poland 11 217 0.6× 162 0.7× 103 0.6× 143 1.1× 102 0.8× 31 390
Mohamed Benchekroun France 13 360 1.1× 221 0.9× 286 1.7× 171 1.3× 108 0.9× 18 626
Qihang Li China 12 229 0.7× 159 0.6× 104 0.6× 157 1.2× 65 0.5× 29 448
Digambar Kumar Waiker India 12 192 0.6× 141 0.6× 132 0.8× 116 0.9× 71 0.6× 21 362
Slavica Filipić Serbia 12 211 0.6× 204 0.8× 178 1.1× 196 1.5× 61 0.5× 30 561
Zhongcheng Cao China 17 486 1.4× 320 1.3× 299 1.8× 133 1.0× 221 1.8× 27 719

Countries citing papers authored by Tomasz Wichur

Since Specialization
Citations

This map shows the geographic impact of Tomasz Wichur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomasz Wichur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomasz Wichur more than expected).

Fields of papers citing papers by Tomasz Wichur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomasz Wichur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomasz Wichur. The network helps show where Tomasz Wichur may publish in the future.

Co-authorship network of co-authors of Tomasz Wichur

This figure shows the co-authorship network connecting the top 25 collaborators of Tomasz Wichur. A scholar is included among the top collaborators of Tomasz Wichur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomasz Wichur. Tomasz Wichur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Wichur, Tomasz, Monika Głuch‐Lutwin, Barbara Mordyl, et al.. (2024). Exploring Novel GSK-3β Inhibitors for Anti-Neuroinflammatory and Neuroprotective Effects: Synthesis, Crystallography, Computational Analysis, and Biological Evaluation. ACS Chemical Neuroscience. 15(17). 3181–3201. 5 indexed citations
3.
Więckowski, Krzysztof, Tomasz Wichur, Joanna Śniecikowska, et al.. (2022). Serotonin 5-HT6 Receptor Ligands and Butyrylcholinesterase Inhibitors Displaying Antioxidant Activity—Design, Synthesis and Biological Evaluation of Multifunctional Agents against Alzheimer’s Disease. International Journal of Molecular Sciences. 23(16). 9443–9443. 7 indexed citations
4.
Wichur, Tomasz, Anna Pasieka, Justyna Godyń, et al.. (2021). Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT6 receptor with anti-aggregation properties against amyloid-beta and tau. European Journal of Medicinal Chemistry. 225. 113783–113783. 21 indexed citations
5.
Wichur, Tomasz, Justyna Godyń, Gniewomir Latacz, et al.. (2021). Development and crystallography-aided SAR studies of multifunctional BuChE inhibitors and 5-HT6R antagonists with β-amyloid anti-aggregation properties. European Journal of Medicinal Chemistry. 225. 113792–113792. 19 indexed citations
6.
Godyń, Justyna, Jakub Jończyk, Anna Pasieka, et al.. (2020). Multidirectional in vitro and in cellulo studies as a tool for identification of multi-target-directed ligands aiming at symptoms and causes of Alzheimer’s disease. Journal of Enzyme Inhibition and Medicinal Chemistry. 35(1). 1944–1952. 15 indexed citations
7.
Wichur, Tomasz, Anna Więckowska, Krzysztof Więckowski, et al.. (2019). 1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer’s disease. European Journal of Medicinal Chemistry. 187. 111916–111916. 45 indexed citations
8.
Panek, Dawid, Anna Więckowska, Jakub Jończyk, et al.. (2018). Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer’s Agents. ACS Chemical Neuroscience. 9(5). 1074–1094. 49 indexed citations
9.
Więckowska, Anna, Tomasz Wichur, Justyna Godyń, et al.. (2018). Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer’s Disease. ACS Chemical Neuroscience. 9(5). 1195–1214. 44 indexed citations
10.
Panek, Dawid, Tomasz Wichur, Justyna Godyń, Anna Pasieka, & Barbara Malawska. (2017). Advances Toward Multifunctional Cholinesterase and β-Amyloid Aggregation Inhibitors. Future Medicinal Chemistry. 9(15). 1835–1854. 29 indexed citations
11.
Więckowska, Anna, Marcin Kołaczkowski, Adam Bucki, et al.. (2016). Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT 6 receptor antagonists. Design, synthesis and biological evaluation. European Journal of Medicinal Chemistry. 124. 63–81. 74 indexed citations
12.
Bajda, Marek, Anna Więckowska, Anna Pasieka, et al.. (2016). Synthesis, Molecular Modelling and Biological Evaluation of Novel Heterodimeric, Multiple Ligands Targeting Cholinesterases and Amyloid Beta. Molecules. 21(4). 410–410. 29 indexed citations
13.
Panek, Dawid, Anna Więckowska, Tomasz Wichur, et al.. (2016). Design, synthesis and biological evaluation of new phthalimide and saccharin derivatives with alicyclic amines targeting cholinesterases, beta-secretase and amyloid beta aggregation. European Journal of Medicinal Chemistry. 125. 676–695. 82 indexed citations
14.
Wichur, Tomasz & Barbara Malawska. (2015). [Multifunctional ligands--a new approach in the search for drugs against multi-factorial diseases].. PubMed. 69. 1423–34. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026